Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Nightingale

Showing results (141-150 of 271) with videos related to

Pageof 28
Sort By:
Journal of Clinical Pharmacology|May 1, 1976
Pharmacokinetics of cephalexin: an evaluation of one- and two-compartment model pharmacokineticsD S Greene, D R Flanagan, R Quintiliani, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1986
Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humansM N Dudley, W C Shyu, C H Nightingale, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1997
Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditisM N Marangos, D P Nicolau, R Quintiliani, et al.
The American Journal of Medicine|April 27, 1987
Economic impact of streamlining antibiotic administrationR Quintiliani, B W Cooper, L L Briceland, et al.
International Journal of Antimicrobial Agents|January 1, 1994
Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophagesC O Onyeji, C H Nightingale, D P Nicolau, et al.
Connecticut Medicine|August 1, 1993
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapyP Belliveau, C H Nightingale, R Quintiliani, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2000
Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infectionC O Onyeji, D P Nicolau, C H Nightingale, et al.
Connecticut Medicine|May 17, 2000
Quinupristin/dalfopristin: a treatment option for vancomycin-resistant EnterococciM K Kim, D P Nicolau, C H Nightingale, et al.
Pharmacoeconomics|June 6, 1996
Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patientsD P Nicolau, J W Ross, R Quintiliani, et al.
International Journal of Antimicrobial Agents|August 5, 2000
Population pharmacokinetics of tobramycin in hospitalized patients receiving once-daily dosing regimenD Xuan, J F Lu, D P Nicolau, et al.
Pageof 28

Showing results (141-150 of 271) with videos related to

Sort By:
Pageof 28
Journal of Clinical Pharmacology|May 1, 1976
Pharmacokinetics of cephalexin: an evaluation of one- and two-compartment model pharmacokineticsD S Greene, D R Flanagan, R Quintiliani, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1986
Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humansM N Dudley, W C Shyu, C H Nightingale, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1997
Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditisM N Marangos, D P Nicolau, R Quintiliani, et al.
The American Journal of Medicine|April 27, 1987
Economic impact of streamlining antibiotic administrationR Quintiliani, B W Cooper, L L Briceland, et al.
International Journal of Antimicrobial Agents|January 1, 1994
Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophagesC O Onyeji, C H Nightingale, D P Nicolau, et al.
Connecticut Medicine|August 1, 1993
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapyP Belliveau, C H Nightingale, R Quintiliani, et al.
The Journal of Antimicrobial Chemotherapy|September 12, 2000
Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infectionC O Onyeji, D P Nicolau, C H Nightingale, et al.
Connecticut Medicine|May 17, 2000
Quinupristin/dalfopristin: a treatment option for vancomycin-resistant EnterococciM K Kim, D P Nicolau, C H Nightingale, et al.
Pharmacoeconomics|June 6, 1996
Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patientsD P Nicolau, J W Ross, R Quintiliani, et al.
International Journal of Antimicrobial Agents|August 5, 2000
Population pharmacokinetics of tobramycin in hospitalized patients receiving once-daily dosing regimenD Xuan, J F Lu, D P Nicolau, et al.
Pageof 28